Unexpected Lower Expression of Oncoprotein Gankyrinin Drug Resistant ABCG2Overexpressing Breast Cancer Cell Lines

BACKGROUND: Development of a multidrug resistance (MDR) phenotype to chemotherapy remains a major barrier in the treatment of cancer. Gankyrin(p28, p28GANKor PSMD10) is an oncoprotein overexpressed in different carcinoma cell lines. The aim of this study was to compare Gankyrin expression level in M...

Descripción completa

Detalles Bibliográficos
Autores principales: Taheri, Maryam, Jamialahmadi, Khadijeh, Kalalinia, Fatemeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980903/
https://www.ncbi.nlm.nih.gov/pubmed/29286612
http://dx.doi.org/10.22034/APJCP.2017.18.12.3413

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980903/
https://www.ncbi.nlm.nih.gov/pubmed/29286612
http://dx.doi.org/10.22034/APJCP.2017.18.12.3413

Ejemplares similares